Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 24, Status: Authorised

Eligible patients and consumers organisations

ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 October 2025, 09:30 (CET) to 29 October 2025, 17:00 (CET)

A path to better include patients’ perspectives in the regulation of medicines

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Tigecycline Accord, tigecycline, Date of authorisation: 17/04/2020, Revision: 7, Status: Authorised

Minutes of the COMP meeting 15-17 July 2025